About

Bart Burgess is the Global Head of Portfolio Strategy and Customer Solutions at SHL Medical, shaping the company’s strategic direction and enhancing customer experiences. Mr Burgess joined SHL in 2022 and has since driven the company’s product development approach. With his extended expertise in business development, primary container technologies and injection device product development, Mr Burgess optimises SHL’s market positioning and maximises the company’s global competitiveness. Before he joined SHL, Mr Burgess held a variety of technical, business development and product strategy roles in pharmaceutical and medical device companies.